Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)

China · Delayed Price · Currency is CNY

25.85

+0.94 (3.77%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Medicine Manufacturing	324.82M	364.18M	548.99M	584.29M	425.21M
Medicine Manufacturing Growth	-10.81%	-33.66%	-6.04%	37.41%	-35.72%
Total	324.82M	364.18M	548.99M	584.29M	425.21M
Total Growth	-10.81%	-33.66%	-6.04%	37.41%	-35.72%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	324.82M	364.18M	548.99M	584.29M	425.21M
China Growth	-10.81%	-33.66%	-6.04%	37.41%	-35.72%
Total	324.82M	364.18M	548.99M	584.29M	425.21M
Total Growth	-10.81%	-33.66%	-6.04%	37.41%	-35.72%

Source: S&P Global Market Intelligence.